Generics
Mylan voluntarily waives exclusive rights to distribute generic version of Kaletra antiretroviral to aid US COVID-19 efforts
26 March 2020 - Mylan (NASDAQ: MYL), a global pharmaceutical company, has voluntarily waived its exclusive rights to distribute its generic version of Kaletra (lopinavir/ritonavir) antiretroviral 100m...
Sandoz acquires distribution rights for daptomycin 500mg injection and fosaprepitant 150mg for injection from BE Pharmaceuticals
24 March 2020 - Sandoz, a Novartis division, has acquired the US distribution rights for daptomycin 500mg injection and fosaprepitant 150mg for injection from BE Pharmaceuticals AG, it was reported on...
Positive Recommendation by NICE for First Anti-CGRP Migraine Therapy Ajovy
12 March 2020 - - The National Institute for Health and Care Excellence has recommended Ajovy (fremanezumab) in its Final Appraisal Document for the prevention of migraine in adults with chronic migra...
Novadoz Pharmaceuticals to launch FDA approved Thiotepa 15mg & 100mg vials for injection in oncology market
9 March 2020 - Novadoz Pharmaceuticals reported on Friday the receipt of approval from the FDA for the generic version of Thiotepa in the 15mg and 100mg vials for injection indicated for treatment of ...
Nuvo Pharmaceuticals reports 'at risk' US launch of generic Vimovo
5 March 2020 - Canadian healthcare company Nuvo Pharmaceuticals Inc (TSX:NRI) (OTCQX:NRIFF) said on Wednesday that Dr. Reddy's Laboratories Inc (DRL) has launched its generic version of Vimovo in...
Dr. Reddy's Laboratories Launches Generic Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the US Market
4 March 2020 - - Indian drugmaker Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) said it has undertaken the first-to-market launch of Naproxen and Esomeprazole Magnesium D...